Avid Bioservices
Private Equity Round in 2024
Avid Bioservices is a contract development and manufacturing organization (CDMO) specializing in biopharmaceutical products. It offers a range of services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submissions support. The company focuses on quality and expertise, tailoring its services to meet the unique needs of its clients, primarily pharmaceutical and biotechnology companies. By outsourcing to Avid, these companies can accelerate the development and manufacturing of their biologics, ultimately bringing new therapies to market more efficiently.
Sapio Sciences
Acquisition in 2022
Sapio Sciences develops advanced software solutions for laboratory management through its Exemplar Seamless Informatics Platform, which includes a Laboratory Information Management System (LIMS), Electronic Lab Notebook (ELN), and Scientific Data Management System (SDMS). The LIMS software allows laboratories to efficiently track processes, materials, and workflows, accessible via a web-based interface without requiring IT support. It offers customizable workflows tailored for various research needs, such as clinical and bioanalytical applications. The ELN facilitates collaboration among scientists by enabling real-time experiment tracking and communication through an intuitive interface. Built on a cloud-hosted platform, Exemplar Seamless integrates a wide range of functionalities, including data visualization and analytics, empowering researchers to configure experiments, manage samples, and analyze results efficiently. The platform's no-code design and AI capabilities enhance usability, making it a comprehensive solution for modern laboratory environments.
Alcami
Acquisition in 2022
Alcami Corporation is a contract development and manufacturing organization (CDMO) based in Wilmington, North Carolina, specializing in services for the pharmaceutical and biotechnology sectors. The company provides a range of offerings, including sterile fill-finish development, oral solid dose development, formulation and analytical development, microbial identification, and stability storage. By focusing on small and mid-sized pharmaceutical and biotech companies, Alcami aims to deliver a streamlined, cost-effective approach to product commercialization, helping clients navigate the complexities of drug development and manufacturing.
Lykan BioScience
Private Equity Round in 2022
Lykan BioScience, LLC is a contract development and manufacturing services organization based in Phoenix, Arizona, established in 2017. The company specializes in providing outsourced end-to-end production and logistics solutions tailored for pharmaceutical and biotech companies. Its comprehensive service offerings include point-of-care solutions, tech transfer, manufacturing, operations access, quality program management, and supply chain management, with a particular focus on cell-based therapies. By integrating these services, Lykan BioScience aims to support clients in bringing innovative therapies to market efficiently and effectively.
RoslinCT
Private Equity Round in 2022
RoslinCT is a UK-based Contract Development and Manufacturing Organisation (CDMO) that specializes in cell and gene therapy. The company offers a range of services tailored for organizations developing cell-based therapeutic products. Its expertise encompasses tissue procurement, cryopreservation studies, pre-clinical studies, and analytical development. By providing these services, RoslinCT enables its clients to create compliant, sustainable, and cost-effective therapies, supporting advancements in the field of regenerative medicine.
Biocare Medical
Private Equity Round in 2021
Biocare Medical, LLC specializes in developing and supplying automated immunohistochemistry (IHC) instrumentation and a comprehensive range of reagents for laboratory testing. The company is recognized as a leader in multiplex IHC tests, which enhance diagnostic confidence and streamline patient therapy processes. Biocare Medical's product offerings include primary antibodies, detection kits, chromogens, and advanced micro-polymer detection systems that provide superior specificity and sensitivity. Additionally, the company provides various ancillary products such as decalcification agents, blocking reagents, and technical support services. Its clientele encompasses clinical histology laboratories, pharmaceutical companies, contract research organizations, biotechnology firms, as well as academic and government institutions. Biocare Medical operates from its headquarters in Pacheco, California, and has established a global distribution network to effectively market its innovative diagnostic solutions. Founded in 1997, the company continues to expand its portfolio to meet the evolving demands of cancer and infectious disease diagnostics.
Genesis Research
Acquisition in 2021
Genesis Research is a global life sciences research and consulting company that offers comprehensive evidence development, management, and communication services. The firm specializes in value evidence strategy, economic modeling, and data analytics, providing clients with the tools necessary to address complex challenges in the life sciences sector. Additionally, Genesis Research features unique offerings such as rapid response analytics, outcomes simulation, and the EVID AI literature search platform, along with collaborative payer data services. By focusing on delivering timely and high-quality solutions, Genesis Research supports life sciences companies in demonstrating product value effectively.
Sanner Group
Private Equity Round in 2021
Sanner Group is a manufacturer specializing in primary plastic packaging systems. The company focuses on producing a wide range of products, including effervescent tablets, test strips, desiccant sachets, capsules, caps, plastic tubes, closures, glass bottles, and aluminum tubes. Sanner Group aims to enhance efficiency in material use while minimizing energy consumption and carbon dioxide emissions. Their offerings are tailored to meet specific needs in various sectors such as medical technology, diagnostics, pharmaceuticals, and consumer healthcare.
ClearView Healthcare Partners
Acquisition in 2021
ClearView Healthcare Partners LLC is a global strategy consulting firm that specializes in providing strategic consulting services to life science companies and investors. Founded in 2007 and based in Newton, Massachusetts, the firm focuses on the pharmaceutical, biotechnology, medical device, and diagnostics sectors. ClearView supports clients through various strategic engagements, including indication prioritization, long-term therapeutic area strategy, due diligence, and clinical development strategy. In addition to new product planning and strategic marketing, the firm offers consulting services for business development and private equity investors, as well as strategic market research. Serving a diverse clientele that ranges from emerging biotechnology firms to established global pharmaceutical companies, ClearView combines industry knowledge and scientific expertise to deliver practical solutions to complex challenges faced by its clients.
Velocity Clinical Research
Acquisition in 2021
Velocity Clinical Research specializes in delivering clinical trial services and data to biopharmaceutical and contract research organizations. The company focuses on facilitating the successful execution of clinical studies by offering comprehensive support in areas such as feasibility assessment, contracting, patient recruitment, study management, and billing. By ensuring a centralized point of contact for these services, Velocity aids its clients in upholding high standards of care while expediting the development and deployment of innovative medical treatments across various therapeutic areas. The company is dedicated to connecting new medications to the patients who need them promptly and effectively.
Envision Pharma Group
Acquisition in 2020
Envision Pharma Group is a scientific communications and technology company that specializes in serving the life sciences sector, including pharmaceutical, biotechnology, and medical device industries. The company collaborates with clients, authors, and the medical publishing community to create and implement evidence-based communication programs in a transparent and compliant manner. Envision provides a comprehensive suite of services that includes artificial intelligence and natural language processing, integrated strategic consulting, scientific communications, health economics and outcomes research, market access, and data analytics. Its software solutions facilitate the development of global medical strategies and support cross-functional teams in managing scientific communications. This enables clients to effectively connect with their audiences and ensures compliance with regulatory standards throughout the product life cycle.
X-Chem
Acquisition in 2020
X-Chem, Inc. is a biotechnology company based in Waltham, Massachusetts, founded in 2009. The company specializes in discovering small molecule leads for high-value therapeutic targets, utilizing its innovative DNA-Encoded Library (DEL)-based discovery services. X-Chem's approach involves the iterative combinatorial synthesis of small molecules, which are linked to DNA tags that document their synthetic history. This unique methodology enables the efficient generation of novel therapeutics, positioning X-Chem as a key player in the biotechnology sector.
Fairjourney Biologics
Venture Round in 2020
Fairjourney Biologics SA is a contract research organization based in Porto, Portugal, founded in 2012. The company specializes in providing comprehensive antibody discovery services, including therapeutics, diagnostics, imaging tools, and research tools such as Llama VHHS antibodies, rodent antibodies, rabbit antibodies, human antibodies, and chicken antibodies. Fairjourney Biologics also offers antibody engineering services like affinity maturation, humanization, and sequence optimization, along with antibody production services that involve recombinant expression of antibodies and their fragments. With over a decade of experience, the company leverages advanced technologies and a team of experienced researchers to deliver high-quality, reliable antibodies tailored to meet the unique needs of its diverse partners, which include venture capital firms, virtual companies, spin-offs, biotech companies, and large pharmaceutical corporations.
Ardena
Acquisition in 2020
Ardena Group is a provider of pharmaceutical development services, specializing in early-stage drug development and manufacturing for small to mid-sized biopharma companies. The company operates as a contract partner, offering a range of services that include pre-clinical and clinical drug development, drug research, manufacturing, and bio-analysis. By guiding clients through the drug discovery process, Ardena helps to create effective and compliant pharmaceutical products for clinical trials, supporting the advancement of innovative therapies in the biopharmaceutical sector.
Sterling Pharma Solutions
Acquisition in 2019
Sterling Pharma Solutions is a provider of development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) tailored to the pharmaceutical industry. The company specializes in outsourced contract manufacturing, offering expertise in API development, medical engineering, project management, and supply chain management. By delivering contract good manufacturing practices (GMP) services, Sterling Pharma Solutions enables its clients to concentrate on their projects throughout the entire product lifecycle, ensuring high-quality support and efficiency in their operations.
BioAgilytix Labs
Venture Round in 2019
BioAgilytix Labs, LLC is a bioanalytical laboratory that specializes in large-molecule bioanalysis for preclinical and clinical studies. Founded in 2008 and headquartered in Durham, North Carolina, with additional locations in Hamburg, Germany, and Boston, Massachusetts, the company provides a range of services including biomarker development, immunogenicity assessments, pharmacokinetics, and cell-based assays. BioAgilytix serves various industries, including pharmaceuticals, biotechnology, animal health, cosmetics, and agricultural biotechnology. The company focuses on supporting drug development across multiple therapeutic areas, including gene therapy, CAR T-cell therapy, biosimilars, and immuno-oncology. By employing a team of highly experienced scientists, BioAgilytix aims to deliver high-quality bioanalytical services that meet regulatory standards and support the success of its partners in their scientific endeavors.
Validant
Acquisition in 2018
Validant is a consulting firm that specializes in compliance and regulatory affairs for the pharmaceutical, biologics, medical device, and diagnostics sectors. The company provides a range of services, including systems design, strategy development, implementation, and responses to health authority enforcement actions. Additionally, Validant offers remediation services to ensure that healthcare products are safe and reliable. Their extensive and versatile network of subject matter experts allows clients to access specialized knowledge tailored to their specific initiatives, enabling prompt and effective support in navigating regulatory challenges.
Linimed
Acquisition in 2018
Linimed GmbH, founded in 1994 and headquartered in Jena, Germany, specializes in home nursing and outpatient care services, focusing on out-of-hospital intensive care. The company operates a network of 52 community care centers across Germany, providing care to approximately 250 patients with severe health issues, including neurological and neuromuscular diseases as well as respiratory conditions. With around 930 employees, Linimed is recognized for its efficient and high-quality care delivery, catering to patients with complex healthcare needs. By emphasizing a specialized community care model, Linimed aims to enhance patient health outcomes while offering cost-effective solutions to the healthcare system.
Alcaliber
Acquisition in 2018
Alcaliber S.A., founded in 1973 and based in Madrid, Spain, specializes in manufacturing active pharmaceutical ingredients (API), narcotic raw materials (NRM), and cannabis products. The company is an independent supplier to the global pharmaceutical industry with a strong track record of over four decades. Alcaliber operates through state-of-the-art production facilities and has built a reputation for high-quality products. Its subsidiary, Linneo Health, further enhances its capabilities in this specialized sector. Alcaliber's integrated approach includes managing the entire production process, from poppy cultivation to the delivery of opiates used in medical treatments, ensuring clients receive tailored solutions.
Caprion
Acquisition in 2016
Caprion Proteomics, Inc. is a clinical research organization based in Montreal, Canada, specializing in proteomics and immune monitoring services for the pharmaceutical and biotechnology sectors. The company provides two primary platforms: ImmuneCarta, which utilizes multiparametric flow cytometry for in-depth analyses of immune responses, and ProteoCarta, which employs gel-free and label-free mass spectrometry to compare protein levels across biological samples for biomarker discovery. Caprion offers a diverse range of services, including cell sorting, functional profiling, biomarker discovery, and various assays, addressing multiple disease areas such as autoimmune, cardiovascular, metabolic, neurology, and infectious diseases. Established in 2000, Caprion is dedicated to advancing precision medicine in drug development through strategic partnerships, including one with Viroclinics-DDL. The company rebranded from Caprion Proteomics GP to its current name in July 2007 and operates as a subsidiary of HistoGeneX NV.
VISUfarma
Acquisition in 2016
VISUfarma is a pan-European ophthalmic specialty pharmaceutical company focused on enhancing eye health across Europe. The company develops, markets, and distributes a diverse range of ophthalmology products and devices, aimed at enabling healthcare providers, including physicians, hospitals, and medical centers, to deliver high-quality eye care to patients. With a clear mission to introduce global innovations in the field of ophthalmology, VISUfarma plays a significant role in advancing eye health solutions within the European market.
Quotient Sciences
Acquisition in 2015
Quotient Sciences is a provider of contract manufacturing services focused on the pharmaceutical sector. The company specializes in formulation development, clinical pharmacology, and both clinical and commercial manufacturing. By offering these services, Quotient Sciences enables pharmaceutical companies to accelerate the development of new drugs through outsourcing various operational processes. This approach allows clients to enhance their efficiency and focus on core competencies while leveraging Quotient Sciences' expertise in drug development.
DNA Diagnostics Center
Acquisition in 2015
DNA Diagnostics Center, Inc., established in 1995 and located in Fairfield, Ohio, specializes in genetic testing services. The company provides a range of DNA tests, including paternity and family relationship assessments, as well as fertility, lifestyle, veterinary, and forensic testing. Utilizing automated precision instrumentation, DNA Diagnostics Center ensures accurate and efficient results, catering to consumers, government agencies, legal professionals, and healthcare practitioners. The service emphasizes privacy and affordability, enabling clients to obtain timely answers to their genetic inquiries.